Table 3 Prevalence and odds of CT and NG infections by study area and anatomical site
City | Sample size | Chlamydia infection n; %(95% CIs*) | Gonococcal infection n; %(95% CIs*) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total a | Anorectal site | Pharyngeal site | Urethral site | Total | Anorectal site | Pharyngeal site | Urethral site | ||||||||||
Nanjing | 102 | 18 | 17.6(11.0–26.7) | 14 | 13.7(8.0–22.3) | 4 | 3.9(1.3–10.3) | 2 | 2(0.4–7.7) | 8 | 7.8(3.7–15.3) | 6 | 5.9(2.4–12.9) | 2 | 2.0(0.4–7.7) | 0 | 0 |
Shenzhen | 182 | 41 | 22.5(16.8–29.4) | 35 | 19.2(13.9–25.8) | 2 | 1.1(0.2–4.3) | 7 | 3.8(1.7–8.0) | 14 | 7.7(4.4–12.8) | 8 | 4.4(2.1–8.8) | 4 | 2.2(0.7–5.9) | 3 | 1.6(0.4–5.1) |
Wuhan | 95 | 10 | 10.5(5.4–18.9) | 10 | 10.5(5.4–18.9) | 0 | 0 | 3 | 3.2(0.8–9.7) | 7 | 7.4(3.3–15.1) | 5 | 5.3(2.0–12.5) | 2 | 2.1(0.4–8.1) | 0 | 0 |
Total | 379 | 69 | 18.2(13.9–22.5) | 59 | 15.6(11.6–19.5) b | 6 | 1.6(0.3–2.9) | 12 | 3.2(1.4–5.0) | 29 | 7.7(5.3–11.0) | 19 | 5.0(3.1–7.8) c | 8 | 2.1(1.0–4.3) | 3 | 0.8(0.2–2.5) |